No Association between PAWR Gene Polymorphisms and Tardive Dyskinesia in Schizophrenia Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Il-Soo | - |
dc.contributor.author | Yoon, Ho-Kyoung | - |
dc.contributor.author | Kang, Seung-Gul | - |
dc.contributor.author | Park, Young-Min | - |
dc.contributor.author | Kim, Yong-Ku | - |
dc.contributor.author | Kim, Seung-Hyun | - |
dc.contributor.author | Choi, Jung-Eun | - |
dc.contributor.author | Kim, Leen | - |
dc.contributor.author | Lee, Heon-Jeong | - |
dc.date.available | 2020-02-29T05:47:19Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2012-06 | - |
dc.identifier.issn | 1738-3684 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/16339 | - |
dc.description.abstract | Tardive dyskinesia (TD) is a hyperkinetic movement disorder associated with the prolonged use of antipsychotic drugs. Since prostate apoptosis response 4 (Par-4) is a key ligand of the dopamine D2 receptor, the Par-4 gene (PAWR) is a good candidate gene to study in the context of TD susceptibility. We examined the association between PAWR gene polymorphisms and TD. Three single nucleotide polymorphisms of PAWR were selected for the analysis: rs7979987, rs4842318, and rs17005769. Two hundred and eighty unrelated Korean schizophrenic patients participated in this study (105 TD and 175 non-TD patients). Genotype/allele-wise and haplotype-wise analyses were performed. There were no significant differences in genotype and allele frequencies between the two groups. Haplotype analysis also did not reveal a difference between the two groups. Within the limitations imposed by the size of the clinical sample, these findings suggest that PAWR gene variants do not significantly contribute to an increased risk of TD. Psychiatry Investig 2012;9:191-194 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN NEUROPSYCHIATRIC ASSOC | - |
dc.relation.isPartOf | PSYCHIATRY INVESTIGATION | - |
dc.subject | RECEPTOR GENE | - |
dc.subject | ALA-9VAL POLYMORPHISM | - |
dc.subject | ANTIPSYCHOTICS | - |
dc.subject | PREVALENCE | - |
dc.subject | SEVERITY | - |
dc.subject | RISK | - |
dc.title | No Association between PAWR Gene Polymorphisms and Tardive Dyskinesia in Schizophrenia Patients | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000305445100015 | - |
dc.identifier.doi | 10.4306/pi.2012.9.2.191 | - |
dc.identifier.bibliographicCitation | PSYCHIATRY INVESTIGATION, v.9, no.2, pp.191 - 194 | - |
dc.identifier.kciid | ART001741134 | - |
dc.identifier.scopusid | 2-s2.0-84863495501 | - |
dc.citation.endPage | 194 | - |
dc.citation.startPage | 191 | - |
dc.citation.title | PSYCHIATRY INVESTIGATION | - |
dc.citation.volume | 9 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Kang, Seung-Gul | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Schizophrenia | - |
dc.subject.keywordAuthor | Tardive dyskinesia | - |
dc.subject.keywordAuthor | PAWR | - |
dc.subject.keywordAuthor | Polymorphism | - |
dc.subject.keywordPlus | RECEPTOR GENE | - |
dc.subject.keywordPlus | ALA-9VAL POLYMORPHISM | - |
dc.subject.keywordPlus | ANTIPSYCHOTICS | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | SEVERITY | - |
dc.subject.keywordPlus | RISK | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.